TFX
Teleflex Incorporated
NYSE: TFX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$134.65
+0.34% today
Updated 2026-07-29
Market cap
$5.93B
P/E ratio
2,680.60
P/S ratio
2.79x
EPS (TTM)
$0.05
Dividend yield
1.01%
52W range
$100 – $139
Volume
0.5M
Teleflex Incorporated (TFX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$134.65
12-Month target
$61.31
2030 Target
—
Intrinsic (DCF)
$106.37
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.8B | $2.8B | $3.0B | $3.0B | $2.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -47.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.